Women make up less than 30% of participants for heart disease clinical trials worldwide, according to a consensus statement from the British Cardiovascular Society, who say this is likely hampering progress in tackling one of the highest causes of ill health and death in women.
Global progress on heart disease in women hampered by lack of clinical trial participants
